3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
99
Observational
4
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Gastrointestinal Stromal Tumors
1
Interventions
tazemetostat
2
regorafenib
2
nirogacestat
2
avapritinib
2
Trabectedin
2
selinexor
1
ripretinib
1
omburtamab I-131
1
olaratumab
1
mifamurtide
1
glucarpidase
1
ganitumab
1
fludarabine phosphate
1
balstilimab
1
anlotinib
1
Whole-Body Irradiation
1
Tacrolimus
1
TH 302
1
Sunitinib
1
Proton Pump Inhibitors
1
Mycophenolic Acid
1
Imatinib Mesylate
1
Hydrocortisone
1
FANG vaccine
1
Everolimus
1
DOXO-EMCH
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Carboxypeptidases
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Imatinib Mesylate
×
Sarcoma
×
Clear all
NCT01613053
2015-04-24
MACS2226
Novartis
No longer available